Goyal Manish Kumar, Yadav Kuldeep Singh, Solanki Ram Kumar
Department of Psychiatry, SMS Medical College, Jaipur, Rajasthan, India.
Indian J Psychiatry. 2021 Jul-Aug;63(4):395-399. doi: 10.4103/psychiatry.IndianJPsychiatry_33_20. Epub 2021 Aug 7.
Thyroid function is commonly considered in the assessment of mood disorders. Reports of thyroid dysregulation in patients with mania are associated with several confounding factors. To eliminate confounding factors, studies of first-episode mania are desirable. This study tried to find out any relationship between thyroid disorders and mania.
The aim of this study is to assess and compare the thyroid profile between first-episode mania and healthy controls and to ascertain the correlation between severity and duration of the manic episode with FT3, FT4, and thyroid-stimulating hormone (TSH) levels.
This was a cross-sectional study conducted in the psychiatry department of a tertiary care hospital. Forty consecutive drug-naïve patients with first-episode mania, diagnosed according to the International Classification of Disease-10 (study group), were matched with 40 healthy controls (control group). Both the groups were compared on the basis of thyroid profile and thyroid levels were correlated with duration and severity of illness in the study group.
Nearly 7.5% of cases in the study group had hyperthyroidism, whereas 5% had subclinical hyperthyroidism. In contrast, normal controls showed 5% and 10% prevalence of hypothyroidism and subclinical hypothyroidism, respectively. A statistically significant lower level of TSH was observed in the study group ( < 0.001), whereas the mean serum levels of FT3 and FT4 were higher in the study group, but the difference was statistically nonsignificant. No significant correlation of thyroid hormones level with duration and severity of illness was noted.
Our findings highlight a higher prevalence of hyperthyroidism in patients with mania and suggest the role of thyroid hormones in mania.
在心境障碍评估中通常会考虑甲状腺功能。躁狂症患者甲状腺功能失调的报告与多个混杂因素有关。为消除混杂因素,对首发躁狂症进行研究很有必要。本研究试图找出甲状腺疾病与躁狂症之间的任何关系。
本研究的目的是评估和比较首发躁狂症患者与健康对照者的甲状腺状况,并确定躁狂发作的严重程度和持续时间与游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)及促甲状腺激素(TSH)水平之间的相关性。
这是一项在三级护理医院精神科进行的横断面研究。根据国际疾病分类第10版诊断的40例连续的首发躁狂症初治患者(研究组)与40例健康对照者(对照组)进行匹配。两组基于甲状腺状况进行比较,且研究组中甲状腺水平与疾病持续时间和严重程度相关。
研究组中近7.5%的病例患有甲状腺功能亢进,而5%患有亚临床甲状腺功能亢进。相比之下,正常对照组甲状腺功能减退和亚临床甲状腺功能减退的患病率分别为5%和10%。研究组中观察到TSH水平在统计学上显著较低(<0.001),而研究组中FT3和FT4的平均血清水平较高,但差异无统计学意义。未发现甲状腺激素水平与疾病持续时间和严重程度有显著相关性。
我们的研究结果突出了躁狂症患者中甲状腺功能亢进的较高患病率,并提示甲状腺激素在躁狂症中的作用。